Charles Schwab’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Charles Schwab’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-61,600	Closed	-$1.86M	–	3097
2016 Q2	$1.86M	Buy	+61,600	New	+$1.25M	﹤0.01%	2106

Charles Schwab's CPXX Position: Q3 2016 in Review

Charles Schwab sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 61,600 shares — an estimated $1.86M sold.

Charles Schwab first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $1.86M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Charles Schwab reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Charles Schwab sold 61,600 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $1.86M.
Charles Schwab first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
Charles Schwab's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $1.86M in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Charles Schwab's 13F filing for Q3 2016, filed 14 Nov 2016.